Abstract
BACKGROUND: The utility of [18 F]FDGPET/CT for characterizing malignant ovarian mass has not been extensively studied. Here, we inves-tigated various parameters that could be useful to differentiate malignant ovarian mass. METHODS: We enrolled 51 female patients (53.4±15.0 years), with 86 ovarian masses, who underwent pretreatment [ 18 F]FDGPET/CT. Thirty six lesions were histopathologically confirmed with ovarian serous adenocarcinoma. Thirty one ovarian masses from gastric cancer and 19 masses from colorectal cancer were diagnosed by histopathological study or clinical follow-up. Ovarian masses were evaluated by size, solidity, and metabolic indices. The degree of solidity was scored from 1 to 5 according to the portion of solid and cyst. Metabolic activity was scored to be either positive (=liver) or negative (<liver). SUVmax (SUVovary) and the ratio of SUVmax of ovary to SUVmean of the liver (ovary/Lratio) were performed. Age, bilaterality and level of CA125 were also compared. In statistical analysis, categorical variables were analyzed using Pear-son's chi-square test, while continuous variables were evaluated either independent student's t-test or Mann-Whitney Test. Receiveroperating-characteristic analysis was used to obtain optimal cutoff values. RESULTS: Serous adenocarcinoma had significantly higher score in all metabolic indices over metastasis. However, there were no differences in all metabolic indices in ovarian metastasis. In contrast, solidity was different between metastatic mass from gastric and colorectal cancer. Ovar-ian metastasis from gastric cancer was significantly solid compared with that from colorectal cancer. In comparison of all three masses, solidity and all metabolic indices were significantly different. Patients with serous adenocarcinoma were older and had higher CA-125 level. Between metastases from gastric and colorectal cancer, there were no differences in age, bilaterality and CA-125. CONCLUSIONS: Metabolic indices such as SUVovary and ovary/Lratio could be useful to differentiate serous adenocarcinoma from metasta-sis. Furthermore, the degree of solidity could play a role in predicting the origin of metastasis. (Cite this article as: Han YH, Moon EH, Kim J, Jeong HJ, Sohn MH, Lim ST. Characterization of malignant ovarian mass on [ 18 F]FDGPET/CT: using metabolic indices and degree of solidity.
| Original language | English |
|---|---|
| Pages (from-to) | 76-82 |
| Number of pages | 7 |
| Journal | Quarterly Journal of Nuclear Medicine and Molecular Imaging |
| Volume | 63 |
| Issue number | 1 |
| DOIs | |
| State | Published - 2019.03 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cystadenocarcinoma
- Fluorodeoxyglucose F18
- Neoplasm metastasis
- Ovarian neoplasm
- Phy computed tomography.
- Positron emission tomogra
- Serous
Quacquarelli Symonds(QS) Subject Topics
- Medicine
Fingerprint
Dive into the research topics of 'Characterization of malignant ovarian mass on [ 18 F]FDG PET/CT: Using metabolic indices and degree of solidity'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver